Maddy Chapman is an Editor & Writer at IFLScience and BioTechniques. She focuses on a diverse range of themes including agriculture and farming, medicine and healthcare, climate change, and environmental services, often exploring the intersections of these topics. Maddy's work has been featured in notable publications, showcasing her commitment to addressing critical issues in the fields of environmental science and health.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Maddy Chapman's articles primarily cover scientific topics, often referencing data. She appears to have a broad interest in various scientific subjects, including space exploration, geology, biology, and medical research. When reaching out to her with pitches or expert insights, consider offering scientifically backed data as evidence.
Given the diversity of Maddy’s coverage spanning from geological scales to animal behavior and medical research, experts with multidisciplinary knowledge across different scientific fields could be well-received by her for interviews or commentary on these wide-ranging topics.
There is no specific geographic focus mentioned for Maddy Chapman's coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Is artificial intelligence the next Dr Dolittle?
By: Maddy Chapman
The World’s Oldest Forest Is In A Small Corner Of England And Dates Back 390 Million Years
By: Maddy Chapman
We explore recent biorobotics developments, including biohybrid lobster bots and a nature-inspired artificial eye, that will make all your sci-fi dreams come true.
By: Maddy Chapman
Ancient genes, modern mice.
By: Maddy Chapman
A human lung-on-a-chip technology that recreates the stresses of an asthma attack offers hope for future treatments.
By: Maddy Chapman
We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation of sequencing.
By: Maddy Chapman
Long-term follow-up from a CAR T cell therapy clinical trial shows potential cures in more than one-third of B-cell lymphoma patients.
By: Maddy Chapman
Here are the latest biotech industry updates, including the program announcement for The Antibody Series 2026.
We spoke to the authors of 'Antigen retrieval-immunofluorescence on free floating sections to visualize the liver lobule and its cellular makeup', recently published in BioTechniques.
Complete the form below to download the infographic. Next Generation Sequencing and quantitative PCR can be used for a whole host of life science applications, including mutation and variant detection, DNA/RNA quantification and liquid biopsy. However, the techniques face a number of challenges. In this infographic, created in collaboration with Bio-Rad, we introduce some of […]
